Study of curcumin immunomodulatory effects on reactive astrocyte cell function

International Immunopharmacology

Volumn 22, Issue 1, 2014, Pages 230-235

  Seyedzadeh, Mir Hadi ^a,b   Safari, Zohreh ^b   Zare, Ahad ^b   Gholizadeh Navashenaq, Jamshid ^a   Razavi, Seyed Alireza ^a   Kardar, Gholam Ali ^a,b   Khorramizadeh, Mohammad Reza ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Astrocyte; Curcumin; Immunomodulatory; Multiple sclerosis

Indexed keywords

CURCUMIN; CYTOKINE; GELATIN; GELATINASE B; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROTROPHIN 3; SOMATOMEDIN; ANTIINFLAMMATORY AGENT; CCL2 PROTEIN, HUMAN; NEUROTROPIN; POLYSACCHARIDE; SOMATOMEDIN C;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL FUNCTION; CELL POPULATION; CENTRAL NERVOUS SYSTEM; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; NERVE CELL INHIBITION; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ZYMOGRAPHY; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MULTIPLE SCLEROSIS;

ANTI-INFLAMMATORY AGENTS; ASTROCYTES; CELL LINE; CHEMOKINE CCL2; CURCUMIN; GENE EXPRESSION REGULATION; HUMANS; IMMUNOMODULATION; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 9; MULTIPLE SCLEROSIS; POLYSACCHARIDES;

EID: 84904168894     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.06.035     Document Type: Article

References (50)

1. A. Nylander, and D.A. Hafler Multiple sclerosis J Clin Invest 122 2012 1180 1188
2. J.L. Bennett, and O. Stuve Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications Clin Neuropharmacol 32 2009 121 132
3. A. Prat, and J. Antel Pathogenesis of multiple sclerosis Curr Opin Neurol 18 2005 225 230 (Pubitemid 40813747)
4. L. Steinman A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage Nat Med 13 2007 139 145
5. P.S. Giacomini, P.J. Darlington, and A. Bar-Or Emerging multiple sclerosis disease-modifying therapies Curr Opin Neurol 22 2009 226 232
6. A. Minagar Current and future therapies for multiple sclerosis Scientifica 2013 2013 249101
7. N. Chainani-Wu Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa) J Altern Complement Med 9 2003 161 168 (Pubitemid 36297021)
8. C.H. Hsu, and A.L. Cheng Clinical studies with curcumin Adv Exp Med Biol 595 2007 471 480
9. J. Barry, M. Fritz, J.R. Brender, P.E. Smith, D.K. Lee, and A. Ramamoorthy Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin J Am Chem Soc 131 2009 4490 4498
10. C. Mohanty, and S.K. Sahoo The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 31 2010 6597 6611
11. C. Jobin, C.A. Bradham, M.P. Russo, B. Juma, A.S. Narula, and D.A. Brenner et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity J Immunol 163 1999 3474 3483 (Pubitemid 29431852)
12. B.B. Aggarwal, and K.B. Harikumar Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Int J Biochem Cell Biol 41 2009 40 59
13. G.Y. Kim, K.H. Kim, S.H. Lee, M.S. Yoon, H.J. Lee, and D.O. Moon et al. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets J Immunol 174 2005 8116 8124
14. C. Natarajan, and J.J. Bright Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes J Immunol 168 2002 6506 6513 (Pubitemid 34620077)
15. S.A. Shirley, A.J. Montpetit, R.F. Lockey, and S.S. Mohapatra Curcumin prevents human dendritic cell response to immune stimulants Biochem Biophys Res Commun 374 2008 431 436
16. F. Yang, G.P. Lim, A.N. Begum, O.J. Ubeda, M.R. Simmons, and S.S. Ambegaokar et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J Biol Chem 280 2005 5892 5901 (Pubitemid 40280072)
17. H. Hanai, T. Iida, K. Takeuchi, F. Watanabe, Y. Maruyama, and A. Andoh et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial Clin Gastroenterol Hepatol 4 2006 1502 1506 (Pubitemid 44880023)
18. C. Rohl, R. Lucius, and J. Sievers The effect of activated microglia on astrogliosis parameters in astrocyte cultures Brain Res 1129 2007 43 52 (Pubitemid 46048779)
19. C. Farina, F. Aloisi, and E. Meinl Astrocytes are active players in cerebral innate immunity Trends Immunol 28 2007 138 145 (Pubitemid 46283692)
20. B.A. Barres, R. Schmid, M. Sendnter, and M.C. Raff Multiple extracellular signals are required for long-term oligodendrocyte survival Development 118 1993 283 295 (Pubitemid 23191629)
21. S.D. Chernausek Insulin-like growth factor-I (IGF-I) production by astroglial cells: regulation and importance for epidermal growth factor-induced cell replication J Neurosci Res 34 1993 189 197 (Pubitemid 23037319)
22. N. Didier, I.A. Romero, C. Creminon, A. Wijkhuisen, J. Grassi, and A. Mabondzo Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability J Neurochem 86 2003 246 254 (Pubitemid 36753865)
23. R.M. Ransohoff, P. Kivisakk, and G. Kidd Three or more routes for leukocyte migration into the central nervous system Nat Rev Immunol 3 2003 569 581 (Pubitemid 37328676)
24. Y. Dong, and E.N. Benveniste Immune function of astrocytes Glia 36 2001 180 190 (Pubitemid 33055906)
25. U. Gimsa, OR A, P Pandiyan, D Teichmann, I Bechmann, and R Nitsch et al. Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152) J Mol Med 82 2004 364 372 (Pubitemid 38887866)
26. W.J. Lee, C.Y. Shin, B.K. Yoo, J.R. Ryu, E.Y. Choi, and J.H. Cheong et al. Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide- stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2) Glia 41 2003 15 24 (Pubitemid 36164281)
27. A. Williams, G. Piaton, and C. Lubetzki Astrocytes - friends or foes in multiple sclerosis? Glia 55 2007 1300 1312 (Pubitemid 47328934)
28. A.J. Fahey, R. Adrian Robins, and C.S. Constantinescu Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells J Cell Mol Med 11 2007 1129 1137 (Pubitemid 350037054)
29. M.R. Khorramizadeh, R. Falak, M. Pezeshki, F. Safavifar, P. Mansouri, and A. Ghahary et al. Dermal wound fibroblasts and matrix metalloproteinases (MMPs): their possible role in allergic contact dermatitis Iran J Allergy Asthma Immunol 3 2004 7 11
30. A. Nair, T.J. Frederick, and S.D. Miller Astrocytes in multiple sclerosis: a product of their environment Cell Mol Life Sci 65 2008 2702 2720
31. L. Xie, X.K. Li, and S. Takahara Curcumin has bright prospects for the treatment of multiple sclerosis Int Immunopharmacol 11 2011 323 330
32. R.M. Srivastava, S. Singh, S.K. Dubey, K. Misra, and A. Khar Immunomodulatory and therapeutic activity of curcumin Int Immunopharmacol 11 2011 331 341
33. R.K. Maheshwari, A.K. Singh, J. Gaddipati, and R.C. Srimal Multiple biological activities of curcumin: a short review Life Sci 78 2006 2081 2087
34. L. Xie, X.K. Li, N. Funeshima-Fuji, H. Kimura, Y. Matsumoto, and Y. Isaka et al. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production Int Immunopharmacol 9 2009 575 581
35. S.M. Agrawal, L. Lau, and V.W. Yong MMPs in the central nervous system: where the good guys go bad Semin Cell Dev Biol 19 2008 42 51 (Pubitemid 350235982)
36. G.M. Liuzzi, M. Trojano, M. Fanelli, C. Avolio, A. Fasano, and P. Livrea et al. Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis Mult Scler 8 2002 222 228 (Pubitemid 34654058)
37. Y. Benesova, A. Vasku, H. Novotna, J. Litzman, P. Stourac, and M. Beranek et al. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis Mult Scler 15 2009 316 322
38. M.E. Muroski, M.D. Roycik, R.G. Newcomer, P.E. Van den Steen, G. Opdenakker, and H.R. Monroe et al. Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis Curr Pharm Biotechnol 9 2008 34 46 (Pubitemid 351266968)
39. V.W. Yong, R.K. Zabad, S. Agrawal, A. Goncalves Dasilva, and L.M. Metz Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators J Neurol Sci 259 2007 79 84 (Pubitemid 47031205)
40. G.M. Liuzzi, T. Latronico, M.T. Brana, P. Gramegna, M.G. Coniglio, and R. Rossano et al. Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients Neurochem Res 36 2011 518 527
41. D. Maimone, G.C. Guazzi, and P. Annunziata IL-6 detection in multiple sclerosis brain J Neurol Sci 146 1997 59 65 (Pubitemid 27116054)
42. N.J. Abbott Astrocyte-endothelial interactions and blood-brain barrier permeability J Anat 200 2002 629 638 (Pubitemid 34823054)
43. J.W. Cho, K.S. Lee, and C.W. Kim Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets Int J Mol Med 19 2007 469 474
44. C.Y. Jin, J.D. Lee, C. Park, Y.H. Choi, and G.Y. Kim Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia Acta Pharmacol Sin 28 2007 1645 1651 (Pubitemid 47493297)
45. Z.J. Zhang, L.X. Zhao, D.L. Cao, X. Zhang, Y.J. Gao, and C. Xia Curcumin inhibits LPS-induced CCL2 expression via JNK pathway in C6 rat astrocytoma cells Cell Mol Neurobiol 32 2012 1003 1010
46. M.J. Carson, R.R. Behringer, R.L. Brinster, and F.A. McMorris Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice Neuron 10 1993 729 740 (Pubitemid 23127975)
47. D. Chesik, N. Wilczak, and J. De Keyser The insulin-like growth factor system in multiple sclerosis Int Rev Neurobiol 79 2007 203 226
48. V.C. Russo, P.D. Gluckman, E.L. Feldman, and G.A. Werther The insulin-like growth factor system and its pleiotropic functions in brain Endocr Rev 26 2005 916 943 (Pubitemid 41770158)
49. P. Ye, G.J. Popken, A. Kemper, K. McCarthy, B. Popko, and A.J. D'Ercole Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression J Neurosci Res 78 2004 472 484 (Pubitemid 39536491)
50. R. Aharoni, R. Eilam, H. Domev, G. Labunskay, M. Sela, and R. Arnon The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice Proc Natl Acad Sci U S A 102 2005 19045 19050 (Pubitemid 43049563)